In a small cohort of Norwegian MS patients, some patients were identified who carried DQB1*0602 or DQB1*0603 without DRB1*1501, but none who were DRB1*1501 without DQB1*0602 [17]. Here, HLA-DRB1 is linked to myeloid sarcoma.